Manmeet Ahluwalia

Cleveland, USA

Manmeet Ahluwalia, MD, FACP is the Dean and Diane Miller Family Endowed Chair in Neuro-Oncology. He is an Associate Professor in the Department of Medicine, Clinic Lerner College of Medicine of Case Western Reserve University (CCLCM) where he subspecializes in treatment of patients with brain tumors and brain metastases. He is the Director, Brain Metastasis Research Program and the Associate Director, Clinical Trials, Operations in the Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center of the Neurological Institute of Cleveland Clinic. He is the Section Head of NeuroOncology Outcomes and is a staff in the Taussig Cancer Institute, Cleveland Clinic and has joint appointment in the Developmental Therapeutics Program, Case Comprehensive Cancer Center.

Dr. Ahluwalia's research focuses on the development of new therapies for patients with brain tumors and brain metastases. He is currently leading several clinical trials involving new targeted therapies as well as treatments targeting tumor blood vessels (angiogenesis) and cancer stem cells. His results have been presented nationally and internationally and have resulted in over 70 editorials, peer-reviewed manuscripts and book chapters. Dr. Ahluwalia serves as the Associate Editor on Tumor Section of Neurosurgery, the official Journal of Congress of Neurological Surgeons (CNS). He is the Associate Editor of ASCO Post, the newsletter of ASCO. He is the Section Editor of NeuroOncology for HemOnc Today. He serves as a reviewer on multiple journals including Cancer, NeuroOncology, Cancer Research, Journal of NeuroOncology, Expert Reviews in Neurotherapeutics, BMC Cancer, Molecular Cancer Research, Expert Review of Anticancer Therapy, Expert Opinion in Pharmacotherapy, Journal of Neurology & Neurophysiology.

Dr. Ahluwalia received his MD degree from the Maulana Azad Medical College, University of Delhi. He completed his residency at Fairview General Hospital and fellowship training at the Roswell Park Cancer Institute.